Polivy
Polatuzumab Vedotin-piiq · Targeted Antibody-Drug Conjugate (ADC)
Indications & Uses
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Contraindications
Hypersensitivity to active ingredient or any formulation excipients.
Side Effects & Warnings
Peripheral sensory neuropathy, myelosuppression, hyperglycemia, rash, fatigue.
Drug & Dietary Interactions
Caution with strong CYP3A inhibitors or inducers; review concurrent medications.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.